Introduction
Phlebitis (mechanical, chemical and bacterial) is a common local complication of peripheral intravenous therapy administered through a peripheral venous cannula (1) . According to the standards of the Infusion Nurses Society (INS), the accepted phlebitis rate is 5% or less (2) . However, research findings suggest that there is a significant discrepancy in reported incidence.
Thus, Webster cites that the phlebitis rate ranges from 2.3% -67% (3) .
No generally accepted classification of predisposing factors for phlebitis exists. A large number of risk factors have been identified in various studies, and they can be classified as those relating to: patients, cannula, administered therapy, and other factors (1, 4) .
Most common patient-related risk factors include:
age, gender, and associated diseases. Incidence of phlebitis increases with age; with most studies
showing that obvious signs of phlebitis were present in approximately 50% of patients over the age of 60 (5) . Although most studies suggest that phlebitis is more prevalent in women, there is still no satisfactory explanation for such findings (6) (7) . Furthermore, conditions that impair circulation(e.g., peripheral vascular disease, and smoking status), and conditions that cause lack of sensation (peripheral neuropathy) increase the risk of phlebitis. Other associated diseases, especially diabetes, can contribute significantly to the occurrence of phlebitis (5) .
Physicochemical properties of the peripheral venous cannula (PVC) material and its size affect the development of phlebitis (3) .The results obtained in the study conducted by Maki and Ringer (8) indicate that the incidence of phlebitis following the use of PTFE (Teflon  ® ) cannulas is 30 % higher than following the use of Vialone (Vialone ® ) cannulas. Choosing an inadequate cannula diameter can increase the rate of phlebitis, and the risk rises with increasing diameter (5) (6) . A smaller diameter PVC that accommodates the patient's veins and prescribed therapy minimizes the risk of phlebitis (9) (10) .
Proper stabilization and securing of the insertion site can significantly reduce the risk of phlebitis, and other phlebitis-related complications (11) (12) (13) . The risk of mechanical phlebitis is significantly lower with a proper primary (proximal) and secondary (distal) stabilization of the cannula (14) . Most current standards and bestpractice guidance indicate that PVC replacement should be considered every 72-96 hours (9, 15) . Results of the previous studies show that the incidence of phlebitis increases three or four days after PVC insertion (8) , or when a cannula is inserted in an antecubital vein (5, 16) or wrist region (8) .
There is a significant risk of the development of chemical phlebitis if the pH and osmolality in the medications and solutions are different in relation to their values in the blood (17) . Hypertonic solutions with an osmolality greater than 450mOsm/l and those with a pH of less than 5.0 are associated with the frequent occurrence of phlebitis (4) (5) 18) . The use of antibacterial medications, primarily from the beta-lactam group, may also increase the risk of chemical phlebitis (18) .
One of the major risks for phlebitis incidence is related to the placement and maintenance of a PVC by insufficiently trained staff and staff with less work experience (19) .
Intravenous therapy is an integral part of professional nursing practice in all healthcare institutions in Serbia and Croatia. A nurse should possess required knowledge and skills for setting up and maintaining IV equipment, the patient's venous system, as well as knowledge of the physicochemical characteristics of the administered medications. Given that intravenous therapy is often accompanied by complications, phlebitis being among the most common, nurses have a responsibility to minimize this incidence, at the same time ensuring that patients receive treatment in an appropriate and timely manner.
Nurses' knowledge and early recognition of risk factors for the development of phlebitis can reduce complications. This improves the quality of care, patient safety, patient satisfaction ratings, and at the same time reduces length of hospital stay and the overall cost of health care.
Therefore, the aim of this study was to assess the nurses' perception of risk factors relating to the patient, cannula and administered therapy, with a special focus on the perception of phlebitis potentials of some medications and solutions.
Method
The study was conducted in three health care institutions in Serbia and Croatia (Novi Sad, Niš and Osijek, respectively), using a cross-sectional, questionnaire method, in September of 2012.
A modified questionnaire of Lanbeck et al. (20) was used as the survey instrument. As it was not copyrighted, that the nurses were not familiar with the specified medication or solution, or that they did not administer it and thus they could not evaluate its phlebitic potentials.
The study included a sample of 102 nurses working in the adult intensive care unit (ICU) (surgical and internal medicine) and anaesthesia department (AD). 
Results
Of the total number of nurses who participated in the study, 23 (22.5%) were male and 79 (77.5%) were female ( Table 1 ).
The mean age of the nurses was 33.2 (SD=7. Rev. Latino-Am. Enfermagem 2015 July-Aug.;23(4):677-84.
The perception of the risk factors for phlebitis
Most nurses considered phlebitis a great problem (n = 69, 67.6%), whose prevalence indicated the quality of the nursing care (n = 67, 65.7%), while one-third considered phlebitis a moderate problem in patient care. Analysis of the other responses shows that nurses recognized some factors that may affect the reduction of the incidence of phlebitis such as: good venipuncture practice, regular and adequate documentation, and administering short-term infusions of medications.
However, more than half of the nurses were unaware that the cannula material and diameter may affect the incidence of phlebitis, and did not distinguish the phlebitic potentials of the flushing solution on cannulas, such as heparin and 0.9% NaCL.
The nurses also recognized the factors that influenced the development of phlebitis, such as choice of devices which facilitate dressing and securing of the intravenous cannula, and the length of time before the infusion system was replaced. The nurses' perceptions were mostly divided in relation to the recommended time of IV medication administration, setting cannula in situ, and the impact of the choice and methods of local anesthetic administration on the reduction of the incidence of phlebitis.
In the nurses' opinion, factors that could lead to phlebitis were: higher medication concentration and medications or solutions with a higher pH, as well as thromboembolic diseases, diabetes mellitus and venous insufficiency.
After analyzing nurses' perceptions about the risk factors for phlebitis, we observed a difference, depending on the level of education (Table 2) . 
Phlebitic potentials of some medications and solutions
Phlebitic potentials of antibiotics, which nurses administered in their everyday practice, were rated from 2.21 to 3.12 (Table 3 ), other medications from 1.90 to 2.77 (Table 4) , and solutions from 1.62 to 3.39 (Table 5) .
Nurses identified Vancomycin (3.12±1.26) and
Benzylpenicillin (3.06±1.13) as antibiotics with the strongest phlebitic potential (Table 3) .
(continue...) (Table 5) . *n = Number of participants who rated the fluid †Standard deviation
Discussion
The aim of this study was to evaluate the perceptions in the study. However, the majority of nurses identified phlebitis as a major problem and its incidence as the indicator of the quality of nursing care.
Comparing the current standards of infusion therapy (9) (10) and the nurses' knowledge about risk factors for phlebitis with our findings, we observed a large gap
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between the two. Namely, although some studies have confirmed that the cannula material influences the development of phlebitis (8) , nurses in our study did not recognize this as a predisposing factor. The reason for this misperception could be interpreted by the increased availability of Teflon ® cannulas. Despite the wide variety of types of intravenous cannula in the European market, the main discriminator in selecting them is their price (21) .
Therefore, institution management often opts for Teflon ® cannula with a more favourable price, as they do in Serbia and Croatia.
For a successful and safe use of intravenous therapy and a reduction of complication rates, it is important to respect the golden rule: "The catheter selected shall be of the smallest gauge and length, with the fewest number of lumens, and shall be the least invasive device needed to accommodate and manage the prescribed therapy"
. Taking into account that 41.2% of nurses chose the largest offered diameter cannula (18G) as a dimension that reduces the risk of phlebitis, while only 21.6% opted for the lowest offered diameter (22G), it could be concluded that the golden rule is not followed by all nurses involved in the study. Since the study was conducted in the intensive care units, we assume that nurses based this decision on their perception that rapid volume restoration, which is often needed by the critically ill, requires a larger cannula diameter, regardless of the possible risk of adverse complications.
Flushing and locking are important procedures that influence both the effectiveness and safety of therapy administered through an intravenous cannula (9) (10) .
Therefore, it is important to select the appropriate solution. Comparing the effectiveness and safety of 0.9% sodium chloride solution versus heparin saline solution as flushing and locking solutions for peripheral intravenous access devices in a prospective controlled trial, Wang et. al., (22) concluded that both agents are equally effective and safe. This was confirmed in our study, where a difference in the phlebitic effect of these two solutions was not perceived by nurses, either.
In contrast, Bertolino et. al. (23) found that the rate of cannula-related phlebitis/occlusions was significantly lower in the group of patients who used heparin as a flushing solution. At the same time, Bertolino et. al. (23) recommend that cost/ benefit analyses should be done before making the final decision on the choice of agents.
In terms of retaining intravenous cannula in situ, nurses' perceptions were greatly divided. Therefore, for successful intravenous medicine management and reduction in associated complications, it is essential to address the issue of the time of cannula replacement.
Taking into account that globally, a large number of patients require intravenous cannulation, clinically indicated versus routine replacement in 72 -96 hours would have a positive effect on health care costs worldwide (24) . Routine replacement of the cannula was and still is the source of an overwhelming expenditure and burden on patients and nurses.
There is still another dilemma to be resolved for successful intravenous medicine management.
Namely, the nurses in clinical practice are faced with a variety of recommendations regarding site selection.
Recommendations of the RCN (9) whereas Benzylpenicillin, classified as a beta-lactam antibiotic, has an irritating effect. Cefuroxime, in our study, was not significantly associated with a higher risk, although it is classified as a beta-lactams. To reduce the rate of phlebitis and avoid a mistake in medication administration known as "failure to check for phlebitis", medications with an extremely acidic pH of 2.5 -3.5
should be diluted with a volume of 200 -500ml (18) . 
Other potent medications identified by nurses

Limitations
Results from this study add information to the body of knowledge on nurses' perceptions about risk factors for phlebitis. However, some limitations should be noted.
The use of a convenience sample, drawn only from the intensive care unit and anesthesiology department from two hospitals in Serbia, and one from Croatia, limits the generalizability of the findings. Future studies should recruit larger random samples of nurses from different settings and across a broader geographical area.
Conclusion
Phlebitis as a common local complication of peripheral intravenous therapy was perceived as a significant problem in clinical practice by nurses who participated in this study. However, some risk factors related to its occurrence, especially risk factors associated with the cannula, were not fully perceived. The majority of nurses did not identify the effects of the cannula material, its diameter, the time before cannula were replaced, and solutions used to flush the cannula as potential risk factors. However, risk factors related to the patient and administered therapy were well known. Namely, nurses were aware of the fact that some underlying diseases increase the incidence of phlebitis, as well as the phlebitic effects of certain medications and solvents, such as Vancomycin, Benzylpenicillin, Calcium Glubionate, Aminophylline and Amiodarone Hydrochloride.
